Perspective: Alaska’s healthcare choices should be driven by scientific evidence rather than political influence.

The piece expresses concern about Dr. Heidi Overton’s nomination as FDA commissioner, specifically regarding her stance on healthcare policies and her qualifications. It emphasizes the importance of scientific evidence in healthcare decision-making, particularly in Alaska, where access to care can be challenging. The authors, a group of healthcare professionals, urge Alaska’s senators to oppose Overton’s confirmation to ensure that federal healthcare decisions prioritize patient safety and scientific integrity over political considerations. They argue that the FDA’s decisions should be grounded in rigorous scientific review to protect the health of Alaskans.